Raymond James & Associates’s AlphaClone Alternative Alpha ETF ALFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,543
Closed -$378K 3748
2020
Q1
$378K Sell
8,543
-228
-3% -$12.6K ﹤0.01% 2622
2019
Q4
$515K Hold
8,771
﹤0.01% 2720
2019
Q3
$476K Buy
8,771
+26
+0.3% +$1.39K ﹤0.01% 2684
2019
Q2
$459K Buy
8,745
+446
+5% +$23K ﹤0.01% 2745
2019
Q1
$418K Buy
8,299
+527
+7% +$24.9K ﹤0.01% 2780
2018
Q4
$329K Sell
7,772
-1,095
-12% -$49.7K ﹤0.01% 2812
2018
Q3
$453K Buy
8,867
+462
+5% +$22.9K ﹤0.01% 2776
2018
Q2
$396K Sell
8,405
-1,033
-11% -$47.5K ﹤0.01% 2845
2018
Q1
$410K Buy
9,438
+957
+11% +$43.1K ﹤0.01% 2693
2017
Q4
$363K Sell
8,481
-550
-6% -$23.2K ﹤0.01% 2736
2017
Q3
$375K Hold
9,031
﹤0.01% 2650
2017
Q2
$358K Hold
9,031
﹤0.01% 2620
2017
Q1
$343K Hold
9,031
﹤0.01% 2613
2016
Q4
$318K Sell
9,031
-10,590
-54% -$373K ﹤0.01% 2595
2016
Q3
$706K Sell
19,621
-139
-0.7% -$4.92K ﹤0.01% 2070
2016
Q2
$661K Sell
19,760
-198
-1% -$6.63K ﹤0.01% 1968
2016
Q1
$669K Sell
19,958
-72
-0.4% -$2.5K ﹤0.01% 1887
2015
Q4
$751K Sell
20,030
-12
-0.1% -$457 ﹤0.01% 1786
2015
Q3
$808K Buy
20,042
+12
+0.1% +$528 ﹤0.01% 1702
2015
Q2
$902K Buy
20,030
+65
+0.3% +$2.98K ﹤0.01% 1790
2015
Q1
$904K Hold
19,965
﹤0.01% 1720
2014
Q4
$846K Hold
19,965
﹤0.01% 1672
2014
Q3
$797K Sell
19,965
-6,643
-25% -$262K ﹤0.01% 1623
2014
Q2
$1.04M Buy
26,608
+2,500
+10% +$93.9K 0.01% 1468
2014
Q1
$917K Buy
24,108
+6,080
+34% +$234K 0.01% 1479
2013
Q4
$679K Buy
18,028
+3,823
+27% +$139K 0.01% 1527
2013
Q3
$499K Buy
+14,205
New +$479K ﹤0.01% 1604

Other funds holding ALFA

Raymond James & Associates's ALFA Position: Q2 2020 in Review

Raymond James & Associates sold out of AlphaClone Alternative Alpha ETF (ALFA) in Q2 2020, closing a stake of 8,543 shares — an estimated $378K sold.

Raymond James & Associates first reported a position in ALFA in Q3 2013 and held it in 27 quarters. The position peaked at $1.04M in Q2 2014. 13 funds tracked by Wall St. Rank hold ALFA as of Q2 2020.

  • Raymond James & Associates reported no remaining AlphaClone Alternative Alpha ETF position as of Q2 2020 after selling out during the quarter.
  • Raymond James & Associates sold 8,543 AlphaClone Alternative Alpha ETF shares in Q2 2020, an estimated $378K.
  • Raymond James & Associates first reported a position in AlphaClone Alternative Alpha ETF in Q3 2013 and held it in 27 quarters.
  • Raymond James & Associates's AlphaClone Alternative Alpha ETF position peaked at $1.04M in Q2 2014.
  • 13 funds tracked by Wall St. Rank held AlphaClone Alternative Alpha ETF as of Q2 2020.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.